Lung Cancer

Official Title: Non-chemotherapy treatment (Ramucirumab plus Pembrolizumab) or usual care for advanced non-small cell lung cancer following immunotherapy

Study Purpose: To compare overall survival in participants previously treated with platinum-based chemotherapy and immunotherapy for stage IV or recurrent non-small cell lung cancer randomized to Pembrolizumab and Ramucirumab versus standard of care. 

Status: Recruiting

Official Title: Aphase 1b/2 Open Label, Randomized Study of Vudalimab in Combination With Chemotherapy or Pembrolizumab In Combination With Chemotherapy as First Line Treatment In Patients with Advanced Non-Small Lung Cancer 

Study Purpose: To find a safe, tolerable, and recommended dose of vudalimab for people with locally advanced (unresectable) or metastatic NSCL when combine with chemotherapy.

Status: Recruiting